Defense Threat Reduction Agency (DTRA) – Joint Science and Technology Office (JSTO) BAA
The Defense Threat Reduction Agency (DTRA) Joint Science and Technology Office (JSTO) issues Broad Agency Announcements to accelerate research and development addressing chemical, biological, radiological, and nuclear (CBRN) threats. JSTO is responsible for applied and transitional biodefense innovation across the Department of Defense, focusing on technologies that improve detection, diagnostics, biosurveillance, environmental monitoring, threat modeling, material protection, and advanced warning systems. Unlike DTRA’s basic research BAA, JSTO emphasizes fielded capability, prototype development, and the transition of research outcomes into deployable medical or operational systems.
Priority research areas include rapid pathogen diagnostics, host–pathogen analytics, aerosol and environmental sensing, molecular threat detection, microbial forensics, radiation dosimetry, decontamination materials, PPE innovation, environmental biosurveillance, synthetic biology safeguards, vaccine platform readiness, and systems-level biodefense architectures. JSTO funding often targets R&D that can evolve into testable prototypes, operational technologies, or end-user tools that improve the resilience of military forces during CBRN incidents.
Projects may include:
Portable or next-generation CBRN detection systems
On-site diagnostics for biothreats or field surveillance
AI/ML for outbreak and environmental threat forecasting
New filtration materials, coatings, or PPE
Decontamination technology or protective biopolymer systems
Radiation monitoring or shielding architectures
Field-ready countermeasure development and validation studies
Cloud-edge biosurveillance pipelines with secure threat reporting
Eligibility is intentionally broad and includes universities, nonprofits, federally funded R&D centers (FFRDCs), small businesses, large contractors, and dual-use technology startups. International participation may be restricted depending on export controls or program sensitivity. Because JSTO emphasizes applied impact and transition potential, for-profit companies with defensible intellectual property, manufacturing capability, or clear commercialization pathways are particularly competitive.
The proposal process often proceeds in multiple stages: initial abstract submission, followed by an invited white paper, and ultimately a full proposal. Review criteria evaluate scientific merit, feasibility, mission relevance, technology maturity, and the likelihood of delivering a fieldable capability, including prototypes or deployable tools that strengthen CBRN preparedness.
Example
– DTRA JSTO: https://www.dtra.mil/
ScienceDocs Support
ScienceDocs has strong expertise in shaping DTRA JSTO research narratives, prototype-readiness plans, CBRN diagnostics, synthetic biology safeguards, environmental biosurveillance, and biodefense data analytics. Our specialists assist with white papers, full proposals, milestone planning, technology transition arguments, and scientific documentation tailored for JSTO reviewers.
Begin expert support at:
https://www.sciencedocs.com/quotes/